What Acculab does

Acculab Life Sciences (operating as Acculab Life or Acculab) is a privately held preclinical Contract Research Organization (CRO) headquartered at 11107 Roselle Street, Suite 204, San Diego, California. The company conducts in vivo and cadaveric preclinical studies for medical devices, pharmaceuticals, biologics, and combination products, spanning small and large animal research models from early-stage feasibility through GLP-compliant safety studies. Its core technical platform is a 16,000 sq ft AAALAC-accredited and OLAW-assured facility equipped with two surgical operating rooms, C-Arm fluoroscopy, IVUS, peripheral vascular Doppler ultrasound, flat-panel imaging, PACS, immune-compromised holding space, necropsy, and histology infrastructure, supplemented by centralized scrub and shared procedure rooms.

The service portfolio covers development testing (small and large molecule support), clinical trial support (immunogenicity and bioanalysis), medical device testing, GLP and non-GLP protocol design, PK/PD studies, safety and efficacy testing, anatomic pathology and histology, custom model development (including tumor and diabetic models), and physician training. The company also rents lab space, conference rooms, and surgical/imaging equipment to external users. Go-to-market is consultative and direct: prospects request a quote, schedule a working conversation, and engage on project-based contracts priced to study scope, animal model complexity, and regulatory requirements. Customer segments span pharmaceutical and biotech companies, medical device developers, and early-stage biotech startups.

Acculab is led by founder Ghassan Kassab, PhD, supported by a team of senior research scientists with prior appointments at UC San Diego, UC Irvine, IUPUI, Aarhus University, and the Henry Ford Heart and Vascular Institute. Distribution leverage comes from research collaborations with UC San Diego, UC Irvine, Scripps Research, and Diomics. The company holds GLP compliance, AAALAC accreditation (since 2015), OLAW assurance, USDA and DEA licensing, and OSHA compliance, which collectively constitute the regulatory credentialing required for FDA-acceptable preclinical submissions.

Name

Acculab

Legal name

AccuLab Life Sciences

Website

https://acculablife.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Preclinical CRO Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Preclinical CRO services
• Animal model research
• GLP safety studies
• Medical device testing
• Pharmacokinetics studies

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Preclinical Contract Research Services: CRO services providing preclinical testing for medical devices, pharmaceuticals, biologics, and combination products. Revenue generated through project-based contracts for study design, execution, and reporting, from early-stage feasibility through GLP safety studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Acculab is a preclinical Contract Research Organization (CRO) that designs and executes in vivo and human cadaveric studies using small and large animal models for pharmaceutical, biotechnology, and medical device developers. Services span the preclinical development lifecycle — from early-stage feasibility studies and custom disease-model development through GLP-compliant safety and efficacy studies, PK/PD studies, anatomic pathology, and physician training. The company supports FDA regulatory submissions and product development for drugs, biologics, devices, and combination products.

Product overview

Acculab is a preclinical Contract Research Organization (CRO) offering a comprehensive portfolio of integrated services for medical device, pharmaceutical, and biologic product development. The core offerings consist of Development Testing Services (small and large molecule support), Clinical Trial Support Services (immunogenicity and bioanalysis), and Medical Device Testing Services. These primary service lines are complemented by specialized offerings including Physician Training, Research Protocol Design, PK/PD Studies, Safety and Efficacy Testing, Anatomic Pathology and Histology, Model Development, and In-Vivo/In-Vitro testing. The company also provides facility and equipment rental options, including surgical suites, lab space, and medical imaging equipment. Acculab supports the full product development lifecycle from early-stage feasibility through GLP preclinical safety studies and physician training, serving clients from startups to established pharmaceutical and medical device companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Development Testing Services

Quantifiable outcome

• AAALAC accreditation maintained continuously since 2015

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• UC San DiegocoreStrategic or Co-development PartnerEstablished research collaboration with University of California San Diego. UC San Diego research groups collaborate with Acculab on preclinical studies in cardiovascular, gastroenterology, and other therapeutic areas.
• UC Irvine (UCI)coreStrategic or Co-development PartnerResearch collaboration with University of California Irvine. UCI researchers work with Acculab on preclinical translational research projects and model development.
• Scripps Research InstitutecoreStrategic or Co-development PartnerCollaboration with Scripps Research, one of the world's premier independent biomedical research institutions. Joint preclinical research and development activities.
• DiomicsminorStrategic or Co-development PartnerResearch collaboration with Diomics, a biotech company. Nature of collaboration focused on preclinical research services and study support.

Scale indicators3 records

Expansion highlights3 records

Broad incumbents

• Charles River Laboratories: Global preclinical and clinical CRO offering discovery, safety assessment, and manufacturing services across multiple therapeutic areas and species. Compares to Acculab as the dominant incumbent in the same preclinical CRO category, with overlapping GLP safety-assessment and large-animal study capabilities.
• WuXi AppTec: China-headquartered CRO/CDMO with extensive preclinical and clinical research services including GLP toxicology and animal model work. Comparable as a large, integrated preclinical CRO competitor with global scale.
• Labcorp (incl. Covance/Fortrea): Large CRO providing preclinical through clinical development services globally, including cardiovascular safety studies. Directly comparable as a top-tier preclinical CRO competitor with broader service portfolio and global footprint.

Direct peers

• Inotiv: Mid-sized preclinical CRO specializing in safety assessment, toxicology, and medical device testing with GLP-compliant facilities. Directly comparable to Acculab as a specialized preclinical CRO serving medical device and pharma clients with similar regulatory credentials.
• Toxikon: Niche preclinical CRO focused on medical device, combination product, and pharmaceutical safety/efficacy testing. Directly comparable to Acculab as a specialist medical-device preclinical CRO with overlapping GLP and large-animal model capabilities.
• American Preclinical Services (APS): Preclinical CRO offering medical device, pharmaceutical, and combination product testing with AAALAC-accredited, GLP-compliant facilities. Comparable to Acculab as a mid-sized specialized preclinical CRO serving similar device/pharma clients.
• Surpass, Inc. Specialty CRO focused on preclinical testing for medical devices and combination products, with deep expertise in vascular, cardiovascular, and endovascular studies. Highly comparable to Acculab as a similarly sized specialist in the same medical-device preclinical niche.
• Alta Sciences (formerly Sinclair Research): Mid-sized CRO offering preclinical safety, pharmacology, and medical device testing with AAALAC-accredited facilities. Comparable to Acculab as a specialized preclinical CRO with similar GLP, AAALAC, and large-animal capabilities.

Emerging players

• PreClinical Research Services (PCRS) / Bionova Scientific: Preclinical services providers with GLP capabilities and specialty disease model development. Comparable to Acculab as smaller-scale preclinical CROs serving biotech and medical device clients with flexible study design.

Others

• Calmi2: Academic-adjacent research organization where Acculab's Research Scientist Xiaomei Guo serves as Associate Professor, focused on cardiovascular and metabolic disease model development. Related as a translational research partner with overlapping scientific expertise and model-development synergies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/acculab-life-sciences

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acculab